Wealth Enhancement Advisory Services’s Integra LifeSciences IART Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$393K	Buy	+20,923	New	+$293K	﹤0.01%	2931
2026 Q1	–	Sell	-13,497	Closed	-$177K	–	3731
2025 Q4	$177K	Sell	13,497 -703	-5%	-$9.35K	﹤0.01%	3311
2025 Q3	$205K	Buy	14,200 +848	+6%	+$11.6K	﹤0.01%	3126
2025 Q2	$180K	Buy	13,352 +1,927	+17%	+$28K	﹤0.01%	3020
2025 Q1	$251K	Buy	+11,425	New	+$269K	﹤0.01%	2580
2024 Q3	–	Sell	-12,929	Closed	-$377K	–	2858
2024 Q2	$377K	Buy	12,929 +2,560	+25%	+$75.9K	﹤0.01%	1827
2024 Q1	$368K	Buy	10,369 +163	+2%	+$6.52K	﹤0.01%	1780
2023 Q4	$444K	Buy	10,206 +2,671	+35%	+$105K	﹤0.01%	1581
2023 Q3	$288K	Buy	+7,535	New	+$317K	﹤0.01%	1768

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wealth Enhancement Advisory Services's IART Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Integra LifeSciences (IART) in Q2 2026: 20,923 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #2931 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in IART as recently as Q4 2025.

Wealth Enhancement Advisory Services first reported a position in IART in Q3 2023 and has held it in 9 quarters since. The position peaked at $444K in Q4 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Wealth Enhancement Advisory Services held 20,923 shares of Integra LifeSciences worth $393K as of Q2 2026.
Integra LifeSciences was a new Wealth Enhancement Advisory Services position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2931 holding.
Wealth Enhancement Advisory Services first reported a position in Integra LifeSciences in Q3 2023 and has held it in 9 quarters since.
Wealth Enhancement Advisory Services's Integra LifeSciences position peaked at $444K in Q4 2023.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.